News

One dose of a human papillomavirus (HPV) vaccine was noninferior to two doses in preventing infection, data from a randomized ...
A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...
We’d like to introduce you to the fellow above, whose name is Jae. When asked what area of study she specializes in, she only ...
"It used to take eight to 10 years to develop a vaccine. But it only took 11 months from the SARS-CoV-2 being gene-sequenced ...
Banning mRNA technology in response to the many missteps of public health officials during the pandemic is a textbook example ...
Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor ...
HONG KONG SAR - Media OutReach Newswire - 22 April 2025 - CK Life Sciences Int'l., (Holdings) Inc. ("the Company") announced that the Company will be presenting new data from its cancer vaccine ...
The path to therapeutic cancer vaccines is strewn with disappointment. In the 20-year history of clinical trials for vaccines that are designed to treat existing cancer by stimulating the immune ...
“She’s an example of this emerging face of cancer that's really quite challenging and quite alarming,” Deignan said.
The effects of COVID-19 continue to reverberate in the cancer risk factors of Americans, a new American Cancer Society study ...
A study published last week suggests that, if vaccine uptake continues to decline, measles will soon be endemic again in the ...
Cancer research is one of the fastest-moving areas in biological science, thanks to global funding of hundreds of billions of dollars each year. Of particular interest are mRNA vaccines ...